Ensuring Data Integrity & Regulatory Confidence
Good Laboratory Practice (GLP) compliance is fundamental to the generation of reliable, reproducible, and regulatory-acceptable non-clinical data. In an increasingly regulated drug development environment, GLP serves as the framework that ensures scientific rigor, transparency, and data integrity throughout study execution and reporting.
Why GLP Matters in Drug Development
Non-clinical data generated under GLP conditions forms the basis for critical regulatory decisions, including progression to first-in-human trials. Regulatory authorities rely on GLP-compliant studies to evaluate the safety profile of new chemical entities, biologics, and formulations before clinical exposure.
GLP compliance ensures that:
- Study conduct follows approved protocols
- Data is traceable, auditable, and reproducible
- Results are scientifically sound and defensible
Core Principles of GLP Compliance
GLP is built on structured processes that govern every stage of non-clinical research. These principles collectively safeguard data quality and reliability.
Key GLP Elements
- Defined study plans and approved protocols
- Accurate data recording and secure archiving
- Qualified personnel and documented training
- Independent quality assurance oversight
- Controlled test systems and validated methods
Quality Assurance and Oversight
An independent Quality Assurance (QA) function is central to GLP compliance. QA units monitor study conduct, verify adherence to protocols, and audit final reports to confirm accuracy and completeness before regulatory submission.
This oversight helps ensure that deviations are identified, addressed, and documented in alignment with regulatory expectations.